GlycoMimetics Inc.

NASDAQ: GLYC · Real-Time Price · USD
15.71
-0.44 (-2.72%)
At close: Jul 02, 2025, 3:58 PM

GlycoMimetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 10K 74.92K 1.16M
Cost of Revenue
35.17K n/a 1.03M 1.01M
Gross Profit
-35.17K 10K -957.23K 146.36K
Operating Income
-32.51M -39.28M -47.4M -63.45M
Interest Income
935.27K 2.38M 714.52K 19.77K
Pretax Income
-37.88M -36.9M -46.69M -63.43M
Net Income
-37.88M -36.9M -93.33M -63.14M
Selling & General & Admin
18.25M 19.21M 19.09M 17.11M
Research & Development
14.26M 20.07M 28.39M 47.49M
Other Expenses
-34.86K n/a n/a n/a
Operating Expenses
32.47M 39.29M 47.48M 64.61M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
32.51M 39.29M 47.48M 64.61M
Income Tax Expense
n/a n/a 46.64M -284.6K
Shares Outstanding (Basic)
64.48M 63.34M 52.53M 51.45M
Shares Outstanding (Diluted)
64.48M 63.34M 52.53M 51.45M
EPS (Basic)
-0.59 -0.58 -1.78 -1.23
EPS (Diluted)
-0.59 -0.58 -1.78 -1.23
EBITDA
-37.84M -39.12M -47.2M -63.18M
EBIT
-37.88M -39.27M -47.4M -63.45M
Depreciation & Amortization
35.17K 153.3K 1.03M 1.01M